Therefore, monitoring asymptomatic mothers with anti-Ro or anti-La antibodies and their fetuses due to potential development of autoimmune diseases can ensure the timely and in-depth treatment to protect their wellbeing. The gene discussed is CALR; the disease is autoimmune disease.